why choose us

First received: September 22, 2025

Clinical Trial: A Study of Rifabutin and MK-4646 in Healthy Participants (MK-4646-004)

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Healthy

Study Type: INTERVENTIONAL


Official Title: An Open-Label Clinical Study to Evaluate the Effects of Multiple Oral Doses of Rifabutin on the Single-Dose Pharmacokinetics of MK-4646 in Healthy Participants

Brief Summary: Researchers have designed a new study medicine called MK-4646 as a new way to treat human immunodeficiency virus (HIV).Rifabutin is a medication used to treat tuberculosis (TB).Researchers want to learn about MK-4646 when taken at the same time as Rifabutin.They want to:Measure a person's blood to find out if the amount of MK-4646 in the blood is the same when MK-4646 is taken alone or with Rifabutin Learn about the safety of MK-4646 when taken alone or with Rifabutin and if people tolerate it

Read more